Bionano Genomics Inc. Common Stock (BNGO)

About BNGO

Bionano Genomics, Inc., together with its subsidiaries, provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, China, Japan, South Korea, Singapore, India, and Australia. The company offers genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal…

Sector

Industrials

Industry

Biotechnology: Laboratory Analytical Instruments

Employees

95

Website

bionano.com/

Fundamentals

1-day range

$1.17$1.24

Market cap

$12.79M

P/E (trailing)

—

P/E (forward)

-1.21

EPS (trailing)

$-5.11

Dividend yield

—

Beta

1.74

Avg. volume

134.2K

Forecasts

2 analyst ratings

Bionano Genomics Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• BNGO

  Bionano Genomics Inc. Common Stock

  $1.19

  ▼ 1.65%
  Market cap $12.79MP/E —
  $1$5.5
• PRPO

  Precipio Inc. Common Stock

  $28.85

  ▼ 1.50%
  Market cap $39.55MP/E —
  $14.28$33.63
• CIRC

  Circle8 Group Inc. Common Stock

  $0.7246

  ▲ 2.34%
  Market cap $60.19MP/E —
  $0.4773$0.98
• RPID

  Rapid Micro Biosystems Inc. Class A Common Stock

  $1.56

  ▼ 3.11%
  Market cap $97.88MP/E —
  $1.52$4.94
• NAUT

  Nautilus Biotechnology Inc. Common Stock

  $0.8828

  ▼ 2.35%
  Market cap $128.53MP/E —
  $0.62$4.31
• LAB

  Standard BioTools Inc. Common Stock

  $0.64

  ▼ 1.54%
  Market cap $339.09MP/E 3.47
  $0.6251$1.72
• PACB

  Pacific Biosciences of California Inc. Common Stock

  $1.4

  ▼ 10.00%
  Market cap $441.05MP/E —
  $1.07$2.73

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Bionano Genomics, Inc. 2026 Q2 - Results - Earnings Call Presentation
  SeekingAlpha · 8/11/2026
• Bionano Genomics Q2 EPS $(0.64) Beats $(0.69) Estimate, Sales $8.171M Beat $7.476M Estimate
  benzinga · 8/10/2026
• Bionano Genomics, Inc. (BNGO) Q2 2026 Earnings Call Transcript
  SeekingAlpha · 8/10/2026
• Bionano Genomics Raises FY2026 Sales Guidance from $30.000M-$33.000M to $31.000M-$33.000M vs $32.137M Est
  Benzinga · 8/10/2026
• Bionano Genomics Sees Q3 Sales $8.200M-$8.600M vs $8.575M Est
  Benzinga · 8/10/2026

• Hastie Alex Reid · August 3, 2026 · Grant

  54.0K
• Mark Adamchak · August 3, 2026 · Grant

  5.0K
• Jonathan Dixon V · August 3, 2026 · Grant

  15.0K
• Mark Oldakowski · August 3, 2026 · Grant

  15.0K
• Mark Adamchak · June 3, 2026 · Tax Withholding

  7 @ $1.3
• Jonathan Dixon V · June 3, 2026 · Tax Withholding

  24 @ $1.3
• Alka Chaubey · June 3, 2026 · Tax Withholding

  24 @ $1.3
• Mark Oldakowski · June 3, 2026 · Tax Withholding

  27 @ $1.3
• Rajkovic Aleksandar · May 14, 2026 · Grant

  9.1K
• Linney Yvonne · May 14, 2026 · Grant

  9.1K
• Kristiina Vuori, MD · May 14, 2026 · Grant

  9.1K
• TWOMEY CHRISTOPHER J · May 14, 2026 · Grant

  9.1K
• BARKER DAVID L · May 14, 2026 · Grant

  9.1K

Institutional Ownership

March 31, 2026

Total shares held

818.9K

Total value held

$529.0K

Institutional holders

28